Medications

Indian drug giant Cipla slashes cancer drug prices

Indian drugs giant Cipla said Friday it has slashed by up to 76 percent prices of generic medicines used to treat brain, lung and kidney cancer in what the company called a "humanitarian move".

Medical research

Mapping the hidden connections between diseases

A new study led by UCL researchers has identified patterns in how common health conditions occur together in the same individuals, using data from 4 million patients in England.

Oncology & Cancer

First seeds of kidney cancer sown in adolescence

The earliest critical genetic changes that can lead to kidney cancer have been mapped by scientists. The first key genetic change occurs in childhood or adolescence, and the resulting cells follow a consistent path to progress ...

Immunology

Mechanism for resistance to immunotherapy treatment discovered

An urgent question for cancer scientists is why immunotherapy achieves dramatic results in some cases but doesn't help most patients. Now, two research groups from Dana-Farber Cancer Institute have independently discovered ...

Cardiology

Cancer, heart disease, stroke deaths down, life span stays put

Heart disease and cancer, which cause of deaths of half of Americans who die each year, continued to loosen their deadly grip in 2013, while rates of deaths attributed to flu and pneumonia surged, the Centers for Disease ...

page 1 from 33

Kidney cancer is a type of cancer that starts in the cells in the kidney.

The two most common types of kidney cancer are renal cell carcinoma (RCC) and urothelial cell carcinoma (UCC) of the renal pelvis. These names reflect the type of cell from which the cancer developed.

The different types of kidney cancer (such as RCC and UCC) develop in different ways, meaning that the diseases have different outlooks (or prognosis), and need to be staged and treated in different ways.

This text uses material from Wikipedia licensed under CC BY-SA